Study of the Efficacy, Safety, and Tolerability of Serlopitant for the Treatment of Chronic Pruritus of Unknown Origin
Clinical trial NCT03841331 · COMPLETED
Trial details
- NCT number
- NCT03841331
- Sponsor
- Vyne Therapeutics Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-01-22
- Primary completion
- 2019-12-10
- Enrollment
- 233
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.